NYSE: CVSCvs Health Corp Stock
$100.45-0.07 (-0.07%)
Updated Oct 5, 2022
CVS Price
$100.45
Fair Value Price
N/A
Market Cap
$131.87B
52 Week Low
$82.20
52 Week High
$111.25
P/E
16.18x
P/B
1.75x
P/S
0.4x
PEG
0.83x
Dividend Yield
2.14%
Revenue
$307.86B
Earnings
$8.17B
Gross Margin
17.4%
Operating Margin
4.25%
Profit Margin
2.7%
Debt to Equity
2.06
Operating Cash Flow
$19B
Beta
0.76
Next Earnings
Nov 2, 2022
Ex-Dividend
Oct 20, 2022
Next Dividend
Nov 1, 2022
Zen Score
–
Industry Average (43)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CVS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CVS ($100.45) is trading below its intrinsic value of $249.11, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CVS is good value based on its earnings relative to its share price (16.18x), compared to the US market average (28.61x)
P/E vs Market Valuation
CVS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CVS due diligence checks available for Premium users.
Be the first to know about important CVS news, forecast changes, insider trades & much more!
CVS News
Valuation
CVS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
16.18x
Industry
23.04x
Market
28.61x
CVS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CVS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CVS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.75x
Industry
3.46x
CVS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CVS price to earnings growth (PEG)
For valuing profitable companies with growth potential
CVS is good value based... subscribe to Premium to read more.
PEG Value Valuation
CVS's financial health
Profit margin
Revenue
$80.6B
Net Income
$3.0B
Profit Margin
3.7%
CVS's Earnings (EBIT) of $13.08B... subscribe to Premium to read more.
Interest Coverage Financials
CVS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$230.3B
Liabilities
$154.8B
Debt to equity
2.06
CVS's short-term liabilities ($68.46B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CVS's long-term liabilities ($86.32B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CVS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CVS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$5.4B
Investing
-$2.1B
Financing
-$2.5B
CVS's operating cash flow ($18.53B)... subscribe to Premium to read more.
Debt Coverage Financials
CVS vs Healthcare Plan Stocks
Cvs Health Stock FAQ
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.